Literature DB >> 21862536

Cost comparison of ranibizumab and bevacizumab.

Timothy L Jackson, Lucy Kirkpatrick.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21862536     DOI： 10.1136/bmj.d5058

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  7 in total

Review 1.  Off-label prescribing in older patients.

Authors:  Stephen H D Jackson; Paul A F Jansen; Arduino A Mangoni
Journal:  Drugs Aging       Date:  2012-06-01       Impact factor: 3.923

2.  Cost analysis comparing adjuvant epimacular brachytherapy with anti-VEGF monotherapy for the management of neovascular age-related macular degeneration.

Authors:  T L Jackson; L Kirkpatrick; G Tang; S Prasad
Journal:  Eye (Lond)       Date:  2012-01-20       Impact factor: 3.775

3.  Targeted intraceptor nanoparticle therapy reduces angiogenesis and fibrosis in primate and murine macular degeneration.

Authors:  Ling Luo; Xiaohui Zhang; Yoshio Hirano; Puneet Tyagi; Péter Barabás; Hironori Uehara; Tadashi R Miya; Nirbhai Singh; Bonnie Archer; Yureeda Qazi; Kyle Jackman; Subrata K Das; Thomas Olsen; Srinivas R Chennamaneni; Brian C Stagg; Faisal Ahmed; Lyska Emerson; Kristen Zygmunt; Ross Whitaker; Christina Mamalis; Wei Huang; Guangping Gao; Sangly P Srinivas; David Krizaj; Judit Baffi; Jayakrishna Ambati; Uday B Kompella; Balamurali K Ambati
Journal:  ACS Nano       Date:  2013-03-20       Impact factor: 15.881

4.  AAV2 delivery of Flt23k intraceptors inhibits murine choroidal neovascularization.

Authors:  Xiaohui Zhang; Subrata K Das; Samuel F Passi; Hironori Uehara; Austin Bohner; Marcus Chen; Michelle Tiem; Bonnie Archer; Balamurali K Ambati
Journal:  Mol Ther       Date:  2014-10-13       Impact factor: 11.454

5.  Modelling cost effectiveness in neovascular age-related macular degeneration: the impact of using contrast sensitivity vs. visual acuity.

Authors:  Thomas Butt; Praveen J Patel; Adnan Tufail; Gary S Rubin
Journal:  Appl Health Econ Health Policy       Date:  2014-06       Impact factor: 2.561

6.  Comparative effectiveness of aflibercept for the treatment of patients with neovascular age-related macular degeneration.

Authors:  Michael Thomas; Shaymaa S Mousa; Shaker A Mousa
Journal:  Clin Ophthalmol       Date:  2013-03-08

7.  Long-Term PEDF Release in Rat Iris and Retinal Epithelial Cells after Sleeping Beauty Transposon-Mediated Gene Delivery.

Authors:  Laura Garcia-Garcia; Sergio Recalde; Maria Hernandez; Jaione Bezunartea; Juan Roberto Rodriguez-Madoz; Sandra Johnen; Sabine Diarra; Corinne Marie; Zsuzsanna Izsvák; Zoltán Ivics; Daniel Scherman; Martina Kropp; Gabriele Thumann; Felipe Prosper; Patricia Fernandez-Robredo; Alfredo Garcia-Layana
Journal:  Mol Ther Nucleic Acids       Date:  2017-08-12
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.